BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3355711)

  • 1. Phenylalanine metabolites as indicators of dietary compliance in children with phenylketonuria.
    Michals K; Lopus M; Matalon R
    Biochem Med Metab Biol; 1988 Feb; 39(1):18-23. PubMed ID: 3355711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenylalanine metabolites in hyperphenylalaninemic children].
    Alvarez Domínguez L; Campistol Plana J; Ribes Rubio A; Riverola de Vecina AT
    An Esp Pediatr; 1992 May; 36(5):371-4. PubMed ID: 1616197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral status in children with phenylketonuria--relationship to nutritional intake and phenylalanine control.
    McMurry MP; Chan GM; Leonard CO; Ernst SL
    Am J Clin Nutr; 1992 May; 55(5):997-1004. PubMed ID: 1570811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
    Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
    Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood phenylalanine control in phenylketonuria: a survey of 10 European centres.
    Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen-Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
    Eur J Clin Nutr; 2011 Feb; 65(2):275-8. PubMed ID: 21119696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal PKU: strategies for dietary treatment and monitoring compliance.
    Matalon R; Michals K; Gleason L
    Ann N Y Acad Sci; 1986; 477():223-30. PubMed ID: 3468827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.
    Nardecchia F; Chiarotti F; Carducci C; Santagata S; Valentini G; Angeloni A; Blau N; Leuzzi V
    Eur J Pediatr; 2017 Jul; 176(7):917-924. PubMed ID: 28540433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylalanine metabolites, attention span and hyperactivity.
    Michals K; Matalon R
    Am J Clin Nutr; 1985 Aug; 42(2):361-5. PubMed ID: 4025205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study.
    Walkowiak D; Bukowska-Posadzy A; Kałużny Ł; Ołtarzewski M; Staszewski R; Musielak M; Walkowiak J
    Adv Clin Exp Med; 2019 Oct; 28(10):1385-1391. PubMed ID: 31469949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K Status in Adherent and Non-Adherent Patients with Phenylketonuria: A Cross-Sectional Study.
    Mozrzymas R; Walkowiak D; Drzymała-Czyż S; Krzyżanowska-Jankowska P; Duś-Żuchowska M; Kałużny Ł; Walkowiak J
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylalanine levels in PKU following minor surgery.
    Fiedler AE; Miller MJ; Bickel H; Cederbaum SD
    Am J Med Genet; 1982 Apr; 11(4):411-4. PubMed ID: 7091185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different phenotypes for phenylalanine hydroxylase deficiency.
    Güttler F; Hansen G
    Ann Clin Biochem; 1977 May; 14(3):124-34. PubMed ID: 869488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of phenylketonuria (PKU).
    McGill JJ
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():55-7. PubMed ID: 11400785
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenylketonuria--change in therapeutic strategies. Study of intellectual development and dietary compliance of young phenylketonuria patients].
    Weglage J; Fünders B; von Teeffelen-Heithoff A; Ullrich K
    Fortschr Med; 1993 Nov; 111(31):485-8. PubMed ID: 8276335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some indices of phenylalanine and tyrosine metabolism in children with phenylketonuria].
    D'iachkova AIa; Lebedev BV
    Vopr Okhr Materin Det; 1969; 14(7):29-32. PubMed ID: 5367726
    [No Abstract]   [Full Text] [Related]  

  • 16. Zinc and copper status of treated children with phenylketonuria.
    Acosta PB; Fernhoff PM; Warshaw HS; Hambidge KM; Ernest A; McCabe ER; Elsas LJ
    JPEN J Parenter Enteral Nutr; 1981; 5(5):406-9. PubMed ID: 7198157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M; Truby H; Boneh A
    Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic control on bone quality in phenylketonuria and mild hyperphenylalaninemia.
    Porta F; Mussa A; Zanin A; Greggio NA; Burlina A; Spada M
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):345-50. PubMed ID: 21336059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled diet in phenylketonuria may cause serum carnitine deficiency.
    Vilaseca MA; Briones P; Ferrer I; Campistol J; Riverola A; Castillo P; Ramon F
    J Inherit Metab Dis; 1993; 16(1):101-4. PubMed ID: 8487489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes beyond phenylalanine: an international perspective.
    Feillet F; MacDonald A; Hartung Perron D; Burton B
    Mol Genet Metab; 2010; 99 Suppl 1():S79-85. PubMed ID: 20123476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.